Interestingly, ROC curve analysis and stepwise MLR analysis of blue module genes revealed that the combination of NCF2, MYO1F, S1PR4, and FCN1 could be used as a noninvasive biomarker for obstructive CAD. This evidence concerns the gene NCF2 and coronary artery disorder.